SEC 8-K filings, insider trades, FDA approvals, Federal Reserve statements, and market-moving events — AI-curated, updated every 60 seconds.
TScan Therapeutics announced positive initial data from Cohort C of the ALLOHA Phase 1 study, with 11 of 14 patients achieving complete donor chimerism within three weeks and 93% s…
MapLight Therapeutics announced topline data from its Phase 2 IRIS trial evaluating ML-004 for autism spectrum disorder treatment. The clinical trial results represent a key milest…
MoonLake's sonelokimab achieved 67% HiSCR75 response rate and 26% inflammatory remission at Week 52 in hidradenitis suppurativa trials, with BLA submission expected September 2026.…
Traws Pharma announced it will resubmit an updated toxicology data package for tivoxavir marboxil to the UK's MHRA in Q3 2026 to advance a Phase 2a human influenza challenge study.…
uniQure announced preliminary six-month data from its Phase I/IIa trial of AMT-260 for refractory mesial temporal lobe epilepsy, with three of six patients achieving 79-100% seizur…
The Federal Reserve Board has taken an enforcement action against a former employee of Bank of Eufaula and SNB Bancshares, Inc. No additional details regarding the nature of the vi…
Ameris Bancorp filed amended and restated bylaws reflecting governance updates through June 18, 2026. The changes establish procedures for shareholder meetings, officer duties, and…
Jaguar Health and Uptown Capital amended their royalty interest agreement to set a monthly minimum payment floor of $750,000 beginning October 1, 2026. The amendment modifies payme…
Silo Pharma announced it regained compliance with Nasdaq's minimum closing bid price requirement as of June 17, 2026, resolving a listing qualification matter. The company continue…
Rumble Inc. filed a third amendment to its certificate of incorporation to change its corporate name to RUM Group Inc., effective June 18, 2026 at 5:00 p.m. Eastern Time. The name …
GRI Bio announced FDA Orphan Drug Designation for GRI-0621 (Tazarotene) to treat Idiopathic Pulmonary Fibrosis, a rare progressive lung disease. The designation provides potential …
Centrus Energy Corp. executed a Seventh Amendment to its Section 382 Rights Agreement, extending the Final Expiration Date to June 30, 2029 and adjusting the Purchase Price to $1,1…
SharkNinja, Inc. adopted amended and restated memorandum and articles of association under Cayman Islands law, effective June 18, 2026. The filing establishes corporate governance …
Mobile Infrastructure Corporation filed an amended and restated incentive award plan governing equity compensation for employees, consultants and board members. The plan modificati…
PDF Solutions stockholders approved the Eleventh Amended and Restated 2011 Stock Incentive Plan on June 16, 2026, increasing authorized share limits and extending the incentive sto…
Silvercrest Asset Management Group and its subsidiaries entered into a second amendment to their credit agreement dated June 18, 2026, with City National Bank, with $10 million in …
The Federal Reserve Board has taken an enforcement action against a former employee of Manufacturers and Traders Trust Company. The specific details of the violation and penalties …
The Federal Reserve Board is requesting public comment on a proposal requiring certain payment stablecoin issuers to maintain effective customer identification programs. The measur…
Focus Universal Inc. filed a Certificate of Amendment to its Articles of Incorporation with the Nevada Secretary of State. The amendment was approved by stockholders holding 51.69%…
Translational Development Acquisition Corp. extended its business combination deadline from June 24, 2026 to up to 12 additional months with sponsor funding. The amendment allows t…